SULAIR Home

Hours

Ask Us

Location

Biology Events

Loading...

Home Page with News Feed

Loading...

 View more news & articles

This Week's FEATURED ACQUISITION:
This Month's FEATURED E-BOOK:
protein-folding-in-silico.jpg Extremophiles.jpg
Protein Folding in Silico: protein folding versus protein structure prediction. Edited by Irena Roterman-Konieczna. [QP551 .P69582125 2012]
Protein folding is a process by which a protein structure assumes its functional shape of conformation, and has been the subject of research since the publication of the first software tool for protein structure prediction. Protein folding in silico approaches this issue by introducing an ab initio model that attempts to simulate as far as possible the folding process as it takes place in vivo, and attempts to construct a mechanistic model on the basis of the predictions made. The opening chapters discuss the early stage intermediate and late stage intermediate models, followed by a discussion of structural information that affects the interpretation of the folding process. The second half of the book covers a variety of topics including ligand binding site recognition, the "fuzzy oil drop" model and its use in simulation of the polypeptide chain, and misfolded proteins. The book ends with an overview of a number of other ab initio methods for protein structure predictions and some concluding remarks. [from publisher]

View list of New Acquisitions, updated weekly
Extremophiles: Sustainable Resources and Biotechnological Implications. Edited by Om V. Singh. 2013
Many extremophilic bio-products are already used as life-saving drugs. Until recently, however, the difficulty of working with these microbes has discouraged efforts to develop extremophilic microbes as potential drug reservoirs of the future. Recent technological advances have opened the door to exploring these organisms anew as sources of products that might prove useful in clinical and environmental biotechnology and drug development. em>Extremophiles features outstanding articles by expert scientists who shed light on broad-ranging areas of progress in the development of smart therapeutics for multiple disease types and products for industrial use. It bridges technological gaps, focusing on critical aspects of extremolytes and the mechanisms regulating their biosynthesis that are relevant to human health and bioenergy, including value-added products of commercial significance as well as other potentially viable products. [from publisher]

« Back